Shortage warning

alert warning
TGA issues warning over ongoing shortages of an arthritis treatment The Therapeutic Goods Administration today (23 February) issued a warning that Bristol-Myers Squibb Australia Pty Ltd had notified them of continuing shortages affecting multiple presentations of abatacept (Orencia) products for the first half of the year. The shortages occurred because of manufacturing capacity constraints, supplier

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Federation for pharmacy
Next Fake cop pharmacy robber sentenced